Clinical Trials Browser

Completed × Kidney Neoplasms × vandetanib × Clear all

NCT00566995 2018-10-30

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Phase 2 Completed

37 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms